Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer

oleh: Naoki Nishio, Nynke S. van den Berg, Stan van Keulen, Brock A. Martin, Shayan Fakurnejad, Nutte Teraphongphom, Stefania U. Chirita, Nicholas J. Oberhelman, Guolan Lu, Crista E. Horton, Michael J. Kaplan, Vasu Divi, A. Dimitrios Colevas, Eben L. Rosenthal

Format: Article
Diterbitkan: Nature Portfolio 2019-11-01

Deskripsi

Imaging metastatic disease burden in lymph nodes is important for surgical decision making. Here, the authors use an antibody-dye conjugate to distinguish between metastatic and benign lymph nodes in head and neck cancer.